Frontera Therapeutics has dosed its first patients in a gene therapy trial for the treatment of X-Linked retinitis pigmentosa (XLRP).

The inaugural Optical Dispensers Australia (ODA) industry conference takes place in Sydney from 28–29 April 2023.

Low intracranial pressure (ICP) could play a role in the development of glaucoma among patients who have normal intraocular pressure (IOP), according to a

CooperVison has expanded the parameters for MyDay toric. The options have been increased by nearly 70% to 4,392 prescriptions, and now match the industry-leading